Segmental overgrowth disorders - Deep sequencing

Gene: AKT2

Amber List (moderate evidence)

AKT2 (AKT serine/threonine kinase 2)
EnsemblGeneIds (GRCh38): ENSG00000105221
EnsemblGeneIds (GRCh37): ENSG00000105221
OMIM: 164731, Gene2Phenotype
AKT2 is in 12 panels

3 reviews

Arina Puzriakova (Genomics England Curator)

Comment on list classification: At least three unrelated families reported with the same activating mosaic c.49G>A (p.E17K) variant in the AKT2 gene. Mild asymmetric overgrowth was seen in 2/3 cases. Sibs from the third family showed early overgrowth but no signs of body asymmetry. Overall the evidence is borderline amber/green. However, as this gene has been expert reviewed as green by Tom Cullup (GOSH) and is likely to be diagnostically relevant, recommending AKT2 is promoted to green status at the next GMS panel update.
Created: 9 Aug 2023, 10:50 a.m. | Last Modified: 9 Aug 2023, 10:50 a.m.
Panel Version: 3.12

Tom Cullup (Great Ormond Street Hospital)

Green List (high evidence)

Hot-spot variant Glu17Lys reported multiple times de novo, at least twice mosaic (21979934; 24285683)
Created: 3 May 2023, 3:46 p.m. | Last Modified: 3 May 2023, 3:46 p.m.
Panel Version: 3.5

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) (MIM 240900)

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Catherine Snow (Genomics England)

Comment on list classification: After consultation with Genomics England clinical team who identified AKT2 in the review paper PMID:28502730 – "4 cases summarised, they all have the same missense variant, and I can’t see if any work has been done re mechanism e.g. gain of function". Advised rating as Amber.
Created: 11 Dec 2019, 11:04 a.m. | Last Modified: 11 Dec 2019, 11:04 a.m.
Panel Version: 1.9

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Amber
  • Other
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Hypoinsulinemic hypoglycemia with hemihypertrophy, OMIM:240900
  • Hypoinsulinemic hypoglycemia and body hemihypertrophy, MONDO:0009416
Tags
Q3_23_promote_green Q3_23_NHS_review recurrent-variant
OMIM
164731
Clinvar variants
Variants in AKT2
Penetrance
Complete
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

9 Aug 2023, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: akt2 has been classified as Amber List (Moderate Evidence).

9 Aug 2023, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: AKT2 were set to 28502730

9 Aug 2023, Gel status: 2

Set mode of pathogenicity

Arina Puzriakova (Genomics England Curator)

Mode of pathogenicity for gene: AKT2 was changed from to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

9 Aug 2023, Gel status: 2

Added Tag, Added Tag, Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_23_promote_green tag was added to gene: AKT2. Tag Q3_23_NHS_review tag was added to gene: AKT2. Tag recurrent-variant tag was added to gene: AKT2.

29 Jan 2021, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: AKT2 were changed from Hypoinsulinemic hypoglycemia with hemihypertrophy,240900; Hypoinsulinemic hypoglycemia with hemihypertrophy; HIHGHH; Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 to Hypoinsulinemic hypoglycemia with hemihypertrophy, OMIM:240900; Hypoinsulinemic hypoglycemia and body hemihypertrophy, MONDO:0009416

11 Dec 2019, Gel status: 2

Set publications

Catherine Snow (Genomics England)

Publications for gene: AKT2 were set to

11 Dec 2019, Gel status: 2

Entity classified by Genomics England curator

Catherine Snow (Genomics England)

Gene: akt2 has been classified as Amber List (Moderate Evidence).

28 Nov 2016, Gel status: 1

panel promoted to version 1

Rebecca Foulger (Genomics England curator)

28 November 2016: Reviews were assessed, and panel was revised according to expert review and additional curation.

7 Nov 2016, Gel status: 1

Set Mode of Inheritance, Added New Source

Rebecca Foulger (Genomics England curator)

AKT2 was added to Regional overgrowth disorderspanel. Source: Other Model of inheritance for gene AKT2 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

7 Nov 2016, Gel status: 1

Added New Source

Rebecca Foulger (Genomics England curator)

AKT2 was added to Regional overgrowth disorderspanel. Sources: Radboud University Medical Center, Nijmegen

7 Nov 2016, Gel status: 0

Created

Rebecca Foulger (Genomics England curator)

AKT2 was created by rfoulger